Joshua Yang Snaps Up Coveted Forbes 30 Under 30 for Healthcare Nomination
Class of 2021 Siebel Scholar Josh Yang from Stanford’s Graduate School of Business snaps up distinguished Forbes 30 Under 30 nomination for his trailblazing work in healthcare venture capital and his biotech startup Nephrosant.
Josh cofounded kidney diagnostics startup Nephrosant, which is based on his research into kidney injury prediction. The company is developing non-invasive tools to measure kidney injuries. Yang also is active in venture capital, performing due diligence and sourcing for Pear Ventures and SeaX ventures on healthcare deals.